神经母细胞瘤血清神经元特异性烯醇化酶检测的临床价值评估
该综述批判性评估了血清NSE在神经母细胞瘤诊断和预后中的价值,指出无明确证据支持其用于诊断和监测,假阳性风险显著,但可能有助于判断晚期患者的死亡风险,尚需进一步验证免疫分析和阈值。
要点
- 无明确证据支持血清NSE用于神经母细胞瘤的诊断和监测。
- 样本溶血和炎症等混杂因素可导致NSE假阳性,降低诊断价值。
- NSE可能有助于评估晚期神经母细胞瘤患者的死亡风险。
核心结论
- 无明确证据支持血清NSE用于神经母细胞瘤的诊断和监测。
- NSE可能有助于定义晚期神经母细胞瘤患者的死亡风险,但需进一步研究验证。
研究设计与样本
- 对现有文献进行批判性评估,评价血清NSE在神经母细胞瘤管理中的诊断和预后价值,重点关注合适阈值水平的定义。
主要发现
- 血清NSE检测常被用于神经母细胞瘤的诊断、风险分层和治疗监测,但权威指南指出其诊断性能较差。
- 混杂因素(如样本溶血)和其他病理生理状况(如炎症)导致假阳性NSE结果的风险显著,妨碍了该检测的诊断价值。
临床怎么用
- 不建议将血清NSE常规用于神经母细胞瘤的诊断和监测。
- 在解读NSE结果时需注意排除样本溶血和炎症等干扰因素。
- NSE或可用于晚期神经母细胞瘤患者的死亡风险评估,但需进一步验证。
局限性
- 需要进一步研究验证目前市售的免疫分析并定义可用于该目的的阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The measurement of neuron-specific enolase (NSE) in serum is frequently requested for diagnosis, risk stratification, and treatment monitoring of neuroblastoma (NB) in the pediatric population. However, authoritative clinical practice guidelines advise about the poor diagnostic performance of NSE. CONTENT: We critically appraised the available literature evaluating the diagnostic and prognostic value of NSE in the management of NB, paying special attention to the definition of appropriate threshold levels. In addition, we discuss the interfering conditions causing artifactual increases of NSE concentrations in serum and potentially influencing the clinical evaluation of patients with suspected NB. SUMMARY: No definitive evidence supports the use of serum NSE for diagnosis and monitoring of NB. The risk of obtaining false-positive NSE results associated with confounders (e.g., sample hemolysis) and other pathophysiologic conditions (e.g., inflammation) is remarkable and hampers the diagnostic value of this test. NSE may be helpful to define the risk of death of patients with NB, mainly in the advanced stages of disease. However, further studies validating currently marketed immunoassays and defining threshold values useful for this scope are warranted.
引用
- Ferraro S, Braga F, Luksch R, et al. Measurement of Serum Neuron-Specific Enolase in Neuroblastoma: Is There a Clinical Role? Clin Chem. 2020. PMID: 32353141. doi:10.1093/clinchem/hvaa073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。